The Ministry of Health made the 20-valent pneumococcal conjugate vaccine (pneumo 20) available for the first time in the Unified Health System (SUS) for people 85 years old or older. The immunizer protects against pneumococcal disease and its severe forms, such as meningitis and pneumonia.
Pneumonia is one of the leading causes of death among the elderly, and the elevated risk for people over 85 years old is related to aging mechanisms themselves. The main factors are the natural process of immune system weakening and the higher frequency of comorbidities in this age group.
According to data from the Ministry of Health, the mortality rate from pneumonia among people over 85 years old was 758.1 elderly deaths per 100,000 inhabitants in 2024, and 743.1 per 100,000 in 2025.
The pneumo 20 had been incorporated into the National Vaccination Calendar in June of this year for children under 5 years old. The vaccine expands protection against 20 serotypes of Streptococcus pneumoniae, a bacterium identified as the most common cause of respiratory infections.




